SCHEMBL25112863

SCHEMBL25112863

c1ccc2c(-c3cc4ccc5cccc6c7cccc8ccc9cccc(c(c3)c4c56)c9c87)c3ccccc3c(-c3ccc(-c4cn5ccccc5n4)cc3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 12/20 0.50
▸ KDM4E B2RXH2 12/20 0.50
▸ NPC1 O15118 10/20 0.50
▸ POLB P06746 1/20 0.50
▸ GFER P55789 3/20 0.49
▸ PKM P14618 5/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ EPHX2 P34913 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ MIF P14174 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.45
▸ SMN1; SMN2 Q16637 7/20 0.44
▸ ALDH1A1 P00352 7/20 0.44
▸ MAPK1 P28482 3/20 0.44
▸ HPGD P15428 5/20 0.44
▸ MAPT P10636 5/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ TP53 P04637 1/20 0.44
▸ TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25112923 0.91 RAB9A (0.52) RAB9AKDM4ENPC1POLBGFER
SCHEMBL25112871 0.91 RAB9A (0.52) RAB9AKDM4ENPC1POLBGFER
SCHEMBL25112782 0.89 RAB9A (0.51) RAB9AKDM4ENPC1POLBGFER
SCHEMBL25112906 0.89 RAB9A (0.49) RAB9AKDM4ENPC1POLBGFER
SCHEMBL25112836 0.87 RAB9A (0.51) RAB9AKDM4ENPC1POLBGFER
SCHEMBL973176 0.85 RAB9A (0.57) RAB9AKDM4ENPC1POLBGFER
SCHEMBL18999385 0.84 RAB9A (0.53) RAB9AKDM4ENPC1POLBGFER
SCHEMBL25112904 0.84 RAB9A (0.44) RAB9AKDM4ENPC1POLBGFER
SCHEMBL13454306 0.84 RAB9A (0.56) RAB9AKDM4ENPC1POLBGFER
SCHEMBL971054 0.84 RAB9A (0.56) RAB9AKDM4ENPC1POLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, PIEZO1, LEF1 RAB9A 1606/4885KDM4E 1371/4885NPC1 2399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback